Latest Allarity Therapeutics News & Updates

See the latest news and media coverage for Allarity. We track all announcements, press releases, and industry mentions in real time, all in one place.

Allarity Therapeutics (Allarity)

Clinical-stage precision medicine company for oncology

allarity.com

Headquarters: Tarpon Springs, United States
Founded year: 2012
Company type: Public company
Number of employees: 10–50
Industry: Pharmaceuticals

Last updated Today

Latest news about Allarity Therapeutics (Allarity)

In short: Allarity secured $20M in financing, achieved CLIA certification for its DRP testing, and advanced stenoparib through clinical milestones.

Company announcements

July 7 Allarity

Allarity Therapeutics announces CLIA certification for DRP testing

It enables in-house biomarker testing for FDA registration trials.

June 30 Allarity

Allarity announces grant of key US patent for stenoparib DRP diagnostic

The patent extends protection into April 2042 and covers methods for selecting patients likely to benefit from stenoparib treatment.

May 15 Allarity

Allarity Therapeutics reports Q1 2026 results and clinical progress

Stenoparib development continues in small cell lung and ovarian cancers, with FDA Fast Track designation and new IP allowance.

May 5 Allarity

Allarity Therapeutics advances stenoparib manufacturing for Phase 3

The campaign is on track for Q3 2026 completion, supporting pivotal ovarian cancer trials and FDA approval. All payments are completed with no further cash needed.

Media coverage

July 29 The Globe and Mail

Allarity Therapeutics Secures $20 Million Structured Note Financing

An update from Allarity Therapeutics ( (ALLR)) is now available. On March 2, 2026, Allarity Therapeutics entered into a note purchase agreement with Streeterville Capital...

July 10 Stockhouse

Allarity Therapeutics Announces Two Patients Now Exceeding One Year of Treatment with Stenoparib in Advanced Ovarian Cancer Trial

- Durable Clinical Benefit Observed Beyond a Year on Treatment in Heavily Pre-Treated Patients Boston (September 16, 2024) — Allarity Therapeutics, Inc. (“Allarity&CloseCurlyDoubleQuote; or the...

July 7 Yahoo Finance

Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration

Allarity Therapeutics, Inc. Allarity Therapeutics is now poised to run its DRP® testing in-house in a CLIA-certified ...

July 3 C bonds

Allarity Therapeutics: Submission Of Matters To A Vote Of Security Holders, Other Events, Financial Statements And Exhibits

Item5.07 Submission of Matters to a Vote of Security Holders. OnJune 26, 2026, Allarity Therapeutics, Inc. (the "Company") held its annual meeting of stockholders (the...

Never miss news about Allarity

Track Allarity and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Allarity competitors & trending companies

Browse news for competitors to Allarity and other trending companies.